Cargando…
Integration Capacity of Human Induced Pluripotent Stem Cell-Derived Cartilage
New cell and tissue sources are needed for the regenerative treatment of articular cartilage damage. Human induced pluripotent stem cells (hiPSCs) are an abundant cell source due to their self-renewal capacity. Hyaline cartilage tissue particles derived from hiPSCs (hiPS-Carts), 1–3 mm in diameter,...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450455/ https://www.ncbi.nlm.nih.gov/pubmed/30129877 http://dx.doi.org/10.1089/ten.tea.2018.0133 |
_version_ | 1783409026201026560 |
---|---|
author | Chen, Xike Yamashita, Akihiro Morioka, Miho Senba, Toshika Kamatani, Takashi Watanabe, Akira Kosai, Azuma Tsumaki, Noriyuki |
author_facet | Chen, Xike Yamashita, Akihiro Morioka, Miho Senba, Toshika Kamatani, Takashi Watanabe, Akira Kosai, Azuma Tsumaki, Noriyuki |
author_sort | Chen, Xike |
collection | PubMed |
description | New cell and tissue sources are needed for the regenerative treatment of articular cartilage damage. Human induced pluripotent stem cells (hiPSCs) are an abundant cell source due to their self-renewal capacity. Hyaline cartilage tissue particles derived from hiPSCs (hiPS-Carts), 1–3 mm in diameter, are one candidate source that can be used for transplantation. When transplanted to fill the defects of articular cartilage, hiPS-Carts form a repair tissue by integrating with each other and with adjacent host tissue. In this study, we analyzed the integration capacity using an in vitro model and found that hiPS-Carts spontaneously integrate with each other in vitro. hiPS-Carts consist of cartilage at the center and perichondrium-like membrane that wraps around the cartilage. The integration started at the perichondrium-like membrane at around 1 week. Then, the integration progressed to the cartilage within 4–8 weeks. RNA sequencing analysis identified a higher expression of FGF18 in the perichondrium-like membrane in hiPS-Carts compared with the central cartilage. The addition of FGF18 to the model accelerated the integration of hiPS-Carts, whereas the addition of a FGFR inhibitor inhibited it. These results suggest that FGF18 secreted from the perichondrium-like membrane plays a role in the integration of hiPS-Carts. Understanding the integration mechanism of hiPS-Carts is expected to contribute to the realization of regenerative treatment for patients with articular cartilage damage. IMPACT STATEMENT: Cartilage particles derived from human induced pluripotent stem cells (hiPS-Carts) are one candidate source for transplants for treatment of articular cartilage damage. This study shows that hiPS-Carts integrate with each other in an in vitro model and analyzed the course of the integration. The integration starts at the perichondrium-like membrane at around 1 week and then progresses to the central cartilage within 4–8 weeks. The results indicate that FGF18 secreted from the perichondrium-like membrane accelerates the initial step of integration. The findings contribute to understanding how hiPS-Carts form repair tissue and provide clue to accelerate healing after transplantation. |
format | Online Article Text |
id | pubmed-6450455 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Mary Ann Liebert, Inc., publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-64504552019-04-08 Integration Capacity of Human Induced Pluripotent Stem Cell-Derived Cartilage Chen, Xike Yamashita, Akihiro Morioka, Miho Senba, Toshika Kamatani, Takashi Watanabe, Akira Kosai, Azuma Tsumaki, Noriyuki Tissue Eng Part A Original Articles New cell and tissue sources are needed for the regenerative treatment of articular cartilage damage. Human induced pluripotent stem cells (hiPSCs) are an abundant cell source due to their self-renewal capacity. Hyaline cartilage tissue particles derived from hiPSCs (hiPS-Carts), 1–3 mm in diameter, are one candidate source that can be used for transplantation. When transplanted to fill the defects of articular cartilage, hiPS-Carts form a repair tissue by integrating with each other and with adjacent host tissue. In this study, we analyzed the integration capacity using an in vitro model and found that hiPS-Carts spontaneously integrate with each other in vitro. hiPS-Carts consist of cartilage at the center and perichondrium-like membrane that wraps around the cartilage. The integration started at the perichondrium-like membrane at around 1 week. Then, the integration progressed to the cartilage within 4–8 weeks. RNA sequencing analysis identified a higher expression of FGF18 in the perichondrium-like membrane in hiPS-Carts compared with the central cartilage. The addition of FGF18 to the model accelerated the integration of hiPS-Carts, whereas the addition of a FGFR inhibitor inhibited it. These results suggest that FGF18 secreted from the perichondrium-like membrane plays a role in the integration of hiPS-Carts. Understanding the integration mechanism of hiPS-Carts is expected to contribute to the realization of regenerative treatment for patients with articular cartilage damage. IMPACT STATEMENT: Cartilage particles derived from human induced pluripotent stem cells (hiPS-Carts) are one candidate source for transplants for treatment of articular cartilage damage. This study shows that hiPS-Carts integrate with each other in an in vitro model and analyzed the course of the integration. The integration starts at the perichondrium-like membrane at around 1 week and then progresses to the central cartilage within 4–8 weeks. The results indicate that FGF18 secreted from the perichondrium-like membrane accelerates the initial step of integration. The findings contribute to understanding how hiPS-Carts form repair tissue and provide clue to accelerate healing after transplantation. Mary Ann Liebert, Inc., publishers 2019-03-01 2019-03-14 /pmc/articles/PMC6450455/ /pubmed/30129877 http://dx.doi.org/10.1089/ten.tea.2018.0133 Text en © Xike Chen et al. 2018; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are cited. |
spellingShingle | Original Articles Chen, Xike Yamashita, Akihiro Morioka, Miho Senba, Toshika Kamatani, Takashi Watanabe, Akira Kosai, Azuma Tsumaki, Noriyuki Integration Capacity of Human Induced Pluripotent Stem Cell-Derived Cartilage |
title | Integration Capacity of Human Induced Pluripotent Stem Cell-Derived Cartilage |
title_full | Integration Capacity of Human Induced Pluripotent Stem Cell-Derived Cartilage |
title_fullStr | Integration Capacity of Human Induced Pluripotent Stem Cell-Derived Cartilage |
title_full_unstemmed | Integration Capacity of Human Induced Pluripotent Stem Cell-Derived Cartilage |
title_short | Integration Capacity of Human Induced Pluripotent Stem Cell-Derived Cartilage |
title_sort | integration capacity of human induced pluripotent stem cell-derived cartilage |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450455/ https://www.ncbi.nlm.nih.gov/pubmed/30129877 http://dx.doi.org/10.1089/ten.tea.2018.0133 |
work_keys_str_mv | AT chenxike integrationcapacityofhumaninducedpluripotentstemcellderivedcartilage AT yamashitaakihiro integrationcapacityofhumaninducedpluripotentstemcellderivedcartilage AT moriokamiho integrationcapacityofhumaninducedpluripotentstemcellderivedcartilage AT senbatoshika integrationcapacityofhumaninducedpluripotentstemcellderivedcartilage AT kamatanitakashi integrationcapacityofhumaninducedpluripotentstemcellderivedcartilage AT watanabeakira integrationcapacityofhumaninducedpluripotentstemcellderivedcartilage AT kosaiazuma integrationcapacityofhumaninducedpluripotentstemcellderivedcartilage AT tsumakinoriyuki integrationcapacityofhumaninducedpluripotentstemcellderivedcartilage |